Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew L Hopkins

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Plos Neglected Tropical Diseases|May 21, 2015
Application of RNAi to Genomic Drug Target Validation in SchistosomesAlessandra Guidi, Nuha R Mansour, Ross A Paveley, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Validity of ligand efficiency metricsChristopher W Murray, Daniel A Erlanson, Andrew L Hopkins, et al.
Plos Neglected Tropical Diseases|August 4, 2012
Whole organism high-content screening by label-free, image-based Bayesian classification for parasitic diseasesRoss A Paveley, Nuha R Mansour, Irene Hallyburton, et al.
Veterinary Surgery : VS|September 2, 2016
Multi-Center Retrospective Evaluation of Screw and Polymethylmethacrylate Constructs for Atlantoaxial Fixation in DogsMegan W Stout Steele, Amy W Hodshon, Andrew L Hopkins, et al.
Nature Chemical Biology|June 19, 2009
A crowdsourcing evaluation of the NIH chemical probesTudor I Oprea, Cristian G Bologa, Scott Boyer, et al.
ACS Medicinal Chemistry Letters|January 24, 2014
Discovery of β2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type ReceptorTonia Aristotelous, Seungkirl Ahn, Arun K Shukla, et al.
Nature|December 14, 2012
Automated design of ligands to polypharmacological profilesJérémy Besnard, Gian Filippo Ruda, Vincent Setola, et al.
Journal of Medicinal Chemistry|November 13, 2004
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2George A Freeman, C Webster Andrews Iii, Andrew L Hopkins, et al.
Nature Reviews. Drug Discovery|October 18, 2008
Genomic-scale prioritization of drug targets: the TDR Targets databaseFernán Agüero, Bissan Al-Lazikani, Martin Aslett, et al.
Scientific Reports|June 25, 2021
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Plos Neglected Tropical Diseases|May 21, 2015
Application of RNAi to Genomic Drug Target Validation in SchistosomesAlessandra Guidi, Nuha R Mansour, Ross A Paveley, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Validity of ligand efficiency metricsChristopher W Murray, Daniel A Erlanson, Andrew L Hopkins, et al.
Plos Neglected Tropical Diseases|August 4, 2012
Whole organism high-content screening by label-free, image-based Bayesian classification for parasitic diseasesRoss A Paveley, Nuha R Mansour, Irene Hallyburton, et al.
Veterinary Surgery : VS|September 2, 2016
Multi-Center Retrospective Evaluation of Screw and Polymethylmethacrylate Constructs for Atlantoaxial Fixation in DogsMegan W Stout Steele, Amy W Hodshon, Andrew L Hopkins, et al.
Nature Chemical Biology|June 19, 2009
A crowdsourcing evaluation of the NIH chemical probesTudor I Oprea, Cristian G Bologa, Scott Boyer, et al.
ACS Medicinal Chemistry Letters|January 24, 2014
Discovery of β2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type ReceptorTonia Aristotelous, Seungkirl Ahn, Arun K Shukla, et al.
Nature|December 14, 2012
Automated design of ligands to polypharmacological profilesJérémy Besnard, Gian Filippo Ruda, Vincent Setola, et al.
Journal of Medicinal Chemistry|November 13, 2004
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2George A Freeman, C Webster Andrews Iii, Andrew L Hopkins, et al.
Nature Reviews. Drug Discovery|October 18, 2008
Genomic-scale prioritization of drug targets: the TDR Targets databaseFernán Agüero, Bissan Al-Lazikani, Martin Aslett, et al.
Scientific Reports|June 25, 2021
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Pageof 5